-
www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dx-safety-rural-healthcare.pdf
July 01, 2024 - Diagnostic Excellence in U.S. Rural Healthcare: A Call to Action
PATIENT
SAFETY
e
Issue Brief 22
re
ostic
Safety in Older Adults
Issue Brief 24
Diagnostic Excellence in U.S. Rural
Healthcare: A Call to Action
PATIENT
SAFETY
e
This page intentionally left blank.
e
Issue Brief 24
Diagnostic Excelle…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-fullreport.pdf
February 01, 2018 - Timely Blood Culture for Children With Sepsis Syndrome
1
Timely Blood Culture for Children with Sepsis
Syndrome
Section 1. Basic Measure Information
1.A. Measure Name
Timely Blood Culture for Children with Sepsis Syndrome
1.B. Measure Number
0229
1.C. Measure Description
Please provide a non-technical …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-fullreport.pdf
May 01, 2018 - Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock
1
Timely Fluid Bolus for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Timely Fluid Bolus for Children with Severe Sepsis or Septic Shock
1.B. Measure Number
0231
1.C. Measure Descript…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
June 01, 2018 - Documentation of Heart Rate During Fluid Resuscitation for Children With Severe Sepsis or Septic Shock
1
Documentation of Heart Rate During Fluid
Resuscitation for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Documentation of Heart Rate During Fluid Resu…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-fullreport.pdf
April 02, 2018 - Timely Antibiotics for Children With Severe Sepsis or Septic Shock
1
Timely Antibiotics for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Timely Antibiotics for Children with Severe Sepsis or Septic Shock
1.B. Measure Number
0230
1.C. Measure Descript…
-
www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
November 01, 2017 - Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions
FINAL REPORT
Estimating the Additional Hospital Inpatient
Cost and Mortality Associated With
Selected Hospital-Acquired Conditions
PREPARED FOR:
Agency for Healthcare Resear…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp6.pdf
May 01, 2013 - Volume 6. Concordance Between the Findings of Epidemiological Studies and Randomized Trials in Nutrition: An Empirical Evaluation and Citation Analysis
Technical Review 17
Nutritional Research Series
Volume 6: Concordance Between the Findings
of Epidemiological Studies and Randomized Trials
in Nutrition: An…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
November 01, 2017 - Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions
FINAL REPORT
Estimating the Additional Hospital Inpatient
Cost and Mortality Associated With
Selected Hospital-Acquired Conditions
PREPARED FOR:
Agency for Healthcare Resear…
-
www.ahrq.gov/sites/default/files/publications/files/hacrate2013_0.pdf
October 01, 2015 - 2013 Annual Hospital-Acquired Condition Rate and Estimates of Cost Savings and Deaths Averted From 2010 to 2013
2013 Annual Hospital-Acquired Condition Rate and
Estimates of Cost Savings and Deaths Averted From
2010 to 2013
Agency for Healthcare Research and Quality
540 Gaither Road
Rockville, MD 20850
www.…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy
1
Assessing the Availability of the Preconception
Component of High-Risk Obstetrical Services by
Estimating the Use of Teratogenic Medications B…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-204-fullreport.pdf
January 01, 2014 - Follow-Up Referral After Positive Developmental Screen
Follow-Up Referral After Positive Developmental
Screen
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Referral after Positive Developmental Screen
1.B. Measure Number
0204
1.C. Measure Description
Please provide a non-technical descri…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
February 01, 2020 - Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report
1
Follow-up Visits for Children Who Are Obese or
Overweight with a Weight-Related Comorbidity
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Visits for Children Who Are Obese or Overweight wi…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
July 01, 2019 - CHIPRA 230: Documentation of BMI Percentile and Weight Classification for Children
1
Documentation of BMI Percentile and Weight
Classification for Children
Section 1. Basic Measure Information
1.A. Measure Name
Documentation of BMI Percentile and Weight Classification for Children
1.B. Measure Number
0230
1…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment
1
Continuity of Insurance: Duration of First Observed
Enrollment
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Duration of First Observed Enrollment
1.B. Measure Number
0156
1.C. Measure Description
Please …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-fullreport.pdf
May 23, 2018 - Continuity of Insurance: Informed Participation
1
Continuity of Insurance: Informed Participation
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Informed Participation
1.B. Measure Number
0153
1.C. Measure Description
Please provide a non-technical description of the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible
1
Continuity of Insurance: Coverage Presumed
Ineligible
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Coverage Presumed Ineligible
1.B. Measure Number
0155
1.C. Measure Description
Please provide a non-technical d…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Tobacco Use and Help With Quitting Among Adolescents
Tobacco Use and Help With Quitting Among
Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Tobacco Use and Help With Quitting Among Adolescents
1.B. Measure Number
0090
1.C. Measure Description
Please provide a non-technical description …
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/diagnostic-safety-transitions-care.pdf
June 01, 2023 - Diagnostic Safety Across Transitions of Care Throughout the Healthcare System: Current State and a Call to Action
PATIENT
SAFETY
e
Issue Brief 11
Diagnostic Safety Across Transitions of
Care Throughout the Healthcare System:
Current State and a Call to Action
This page intentionally left blank.
e
Issue …
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2020-Compendium-TechDoc-rev.pdf
January 01, 2020 - Compendium of U.S. Health Systems, 2020, Technical Documentation
Comparative Health System Performance Initiative:
Compendium of U.S. Health Systems, 2020, Technical
Documentation
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
R…
-
www.ahrq.gov/downloads/pub/prevent/pdfser/chdser.pdf
December 08, 2003 - Screening for Asymptomatic Coronary Artery Disease: Systematic Evidence Review
This report may be used, in whole or in part, as the basis for development of clinical practice
guidelines and other quality enhancement tools, or a basis for reimbursement and coverage…